Neoadjuvant Immunotherapy Appears Promising for Muscle-Invasive Bladder Cancer
Investigators compared the rate of downstaging associated with neoadjuvant immunotherapy in patients with muscle-invasive bladder cancer.
United States Jackson Schmidt National Cancer Data Oregon Health Science University In Portland Cancer Data Oregon Health
Source: oncologynurseadvisor.com